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Abstract
Background:  Potassium dichromate (K2Cr2O7)-induced nephrotoxicity is associated with
oxidative and nitrosative stress. In this study we investigated the relation between the time course
of the oxidative and nitrosative stress with kidney damage and alterations in the following
antioxidant enzymes: Cu, Zn superoxide dismutase (Cu, Zn-SOD), Mn-SOD, glutathione
peroxidase (GPx), glutathione reductase (GR), and catalase (CAT).
Methods: Nephrotoxicity was induced in rats by a single injection of K2Cr2O7. Groups of animals
were sacrificed on days 1,2,3,4,6,8,10, and 12. Nephrotoxicity was evaluated by histological studies
and by measuring creatinine clearance, serum creatinine, blood urea nitrogen (BUN), and urinary
excretion of N-acetyl-β -D-glucosaminidase (NAG) and total protein. Oxidative and nitrosative
stress were measured by immunohistochemical localization of protein carbonyls and 3-
nitrotyrosine, respectively. Cu, Zn-SOD, Mn-SOD, and CAT were studied by
immunohistochemical localization. The activity of total SOD, CAT, GPx, and GR was also measured
as well as serum and kidney content of chromium and urinary excretion of NO2 
-/NO3
-. Data were
compared by two-way analysis of variance followed by a post hoc test.
Results: Serum and kidney chromium content increased reaching the highest value on day 1.
Nephrotoxicity was made evident by the decrease in creatinine clearance (days 1–4) and by the
increase in serum creatinine (days 1–4), BUN (days 1–6), urinary excretion of NAG (days 1–4), and
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total protein (day 1–6) and by the structural damage to the proximal tubules (days 1–6). Oxidative
and nitrosative stress were clearly evident on days 1–8. Urinary excretion of NO2
-/NO3
- decreased
on days 2–6. Mn-SOD and Cu, Zn-SOD, estimated by immunohistochemistry, and total SOD
activity remained unchanged. Activity of GPx decreased on days 3–12 and those of GR and CAT
on days 2–10. Similar findings were observed by immunohistochemistry of CAT.
Conclusion: These data show the association between oxidative and nitrosative stress with
functional and structural renal damage induced by K2Cr2O7. Renal antioxidant enzymes were
regulated differentially and were not closely associated with oxidative or nitrosative stress or with
kidney damage. In addition, the decrease in the urinary excretion of NO2
-/NO3
- was associated with
the renal nitrosative stress suggesting that nitric oxide was derived to the formation of reactive
nitrogen species involved in protein nitration.
Background
K2Cr2O7 is a chemical compound that is widely used in
metallurgy, chrome plating, chemical industry, textile
manufacture, wood preservation, photography and pho-
toengraving, refractory and stainless steel industry, and
cooling systems [1]. Occupational exposure to chromium
has been associated with welders, chrome-plating work-
ers, and chromium pigment factories workers [2]. Chro-
mium is known to cause allergic dermatitis [3],
carcinogenicity [4], and ARF in humans [2,5,6] and in ani-
mals [7-11].
Acute renal failure (ARF) induced by potassium dichro-
mate (K2Cr2O7) has been used as a model to study the
pathophysiology of this disease [7,9]. Experimental data
show that chromate affects selectively the convoluted sec-
tion of the proximal tubules [7,12-15] and induces acute
necrosis of renal tubules [14,15]. Clinical and experimen-
tal renal damage induced by K2Cr2O7 has been associated
with oxidative stress [15-20]. In fact, some antioxidants
such as ascorbic acid, vitamin E, N-acetyl cysteine, and
glutathione prevent the K2Cr2O7 induced renal damage
[21-25] whereas the inhibition of glutathione biosynthe-
sis enhances it [22,24]. Evidences suggest that reactive
oxygen species (ROS) are involved in Cr(VI)-induced cell
injury [16,17,19,26]. Chromium reduction intermediates
[Cr(V), Cr(IV), and Cr(III)], which could be generated
under physiological conditions, may be toxic as they
involve ROS production [27-29]. In vitro chromate reduc-
tion via H2O2 has been shown to produce hydroxyl radi-
cals via a Fenton-like reaction [27,30-33].
We recently showed that stannous chloride (SnCl2) pre-
treatment has a protective role in K2Cr2O7-induced neph-
rotoxicity [15,34]. SnCl2 is a potent inductor of heme
oxygenase-1 [15,35] and the protective role of SnCl2 in
this experimental model has been attributed, at least in
part, to the heme oxygenase-1 preinduction [15,34]. We
also showed that renal activity of Cu, Zn-SOD, Mn-SOD,
and GR remained unchanged at 24 and 48 h whereas GPx
and CAT activities remained unchanged at 24 h but
decreased at 48 h in K2Cr2O7-injected rats. In the present
work we performed a time course study of functional and
structural renal damage, oxidative and nitrosative stress,
and the behavior of the antioxidant enzymes Cu, Zn
superoxide dismutase (Cu, Zn-SOD), Mn superoxide dis-
mutase (Mn-SOD), glutathione reductase (GR), glutath-
ione peroxidase (GPx), and catalase (CAT) in K2Cr2O7-
induced nephrotoxicity to know if the antioxidant
enzymes respond in a coordinate way and if there is an
association between (a) oxidative/nitrosative stress and
renal damage, (b) oxidative/nitrosative stress and the anti-
oxidant enzymes, and (c) antioxidant enzymes and renal
damage.
Methods
Reagents
Formaldehyde, anhydrous absolute ethanol, xylol, meth-
anol, chloroform, and K2Cr2O7 were from J.T. Baker (Méx-
ico, D.F.), p-nitrophenyl-N-acetyl-β -D-glucosaminide,
acrylamide, NADPH, N, N'-methylene-bis-acrylamide,
xanthine, xanthine oxidase, nitroblue tetrazolium (NBT),
β -nicotinamide adenine dinucleotide phosphate, reduced
form (β -NADPH), aprotinin, leupeptin, pepstatin, and
2,4-dinitrophenylhydrazine (DNPH) were from Sigma
Chemical Co. (St. Louis, MO, USA). Commercial kits to
measure creatinine and blood urea nitrogen were from
Spinreact (Girona, Spain). Rabbit anti-rat polyclonal anti-
bodies against Mn-SOD (Cat. # SOD 111) and Cu, Zn-
SOD (Cat. # SOD 101) were from Stressgen Biotechnolo-
gies Co. (Victoria, BC, Canada). Rabbit anti-human CAT
polyclonal antibodies (Cat. # 219010) were from Calbio-
chem (San Diego, CA, USA). Goat anti-dinitrophenol
(DNP) polyclonal antibodies (Cat. # J06) were from
Biomeda Corporation (Foster City, CA, USA). Rabbit anti-
3-nitrotyrosine (3-NT) polyclonal antibodies (Cat. #06-
284) were from Upstate (Lake Placid, NY, USA). Anti-rab-
bit immunoglobulin horseradish peroxidase antibodies
(Cat. # NA-934) were from Amersham (Buckinghamshire,
UK). Donkey anti-goat horseradish peroxidase antibodies
(Cat. # SC2020) were from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). Enhanced chemiluminiscenceBMC Nephrology 2005, 6:4 http://www.biomedcentral.com/1471-2369/6/4
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(ECL) kit for Western blot was purchased from Amersham
Life Sciences (Buckinghamshire, England). All other
chemicals were reagent grade and commercially available.
Experimental design
Seven-week-old male Wistar rats with an initial body
weight of 200–210 g were used. Experimental work was
approved by CONACYT (#25441) and DGAPA
(IN210201) and followed the guidelines of Norma Ofi-
cial Mexicana (NOM-ECOL-087-1995). Two groups of
rats were studied: 1) CT, control injected subcutaneously
with 0.5 ml isotonic saline solution (n = 40); and 2)
K2Cr2O7, treated with a single subcutaneous injection of
15 mg/Kg K2Cr2O7 [7] in a volume of 0.5 ml (n = 43). The
study was performed in two stages: rats from days 1,2,3,4,
and 6 were studied in the first one (n = 5/per group) and
rats from days 8, 10, and 12 were studied in the second
one (n = 5 for control group and n = 6 for K2Cr2O7 group).
Rats were sacrificed on days 1,2,3,4,6,8,10, and 12. There
was no mortality. Rats had free access to water and CT
group was pair-fed to match the food intake of K2Cr2O7
group. Animals were maintained in metabolic cages to
collect 24-h urine to measure N-acetyl-β -D-glucosamini-
dase (NAG), total protein, creatinine, and NO2
-/NO3
-.
Animals were sacrificed by decapitation and trunk blood
was collected at room temperature to obtain serum to
measure chromium content and the markers of renal
function, creatinine and blood urea nitrogen (BUN).
Glomerular filtration rate was estimated by creatinine
clearance. The kidneys were obtained to perform histolog-
ical analysis, chromium determination, the activity of
antioxidant enzymes, Western blot of CAT, Cu, Zn-SOD,
and Mn-SOD, and the immunohistochemical localization
of 3-NT, protein carbonyls, CAT, Cu, Zn-SOD, and Mn-
SOD.
Chromium concentration
Chromium content in serum and in total kidney was
measured by graphite-furnace atomic-absorption spec-
trometry on a Perkin Elmer 3110 device with furnace.
Markers of nephrotoxicity
Creatinine and BUN were measured using commercial
kits according to the instructions of manufacturers and
were expressed as mg/dL. Creatinine clearance was calcu-
lated with the serum and urine data according to the
standard formula. Urinary NAG excretion was determined
at 405 nm using p-nitrophenyl-N-acetyl-β -D-glucosamin-
ide as substrate and the data were expressed as U/24 h
[7,15]. One unit of NAG was defined as the amount of
enzyme that releases 1 µmol of p-nitrophenol in the assay
conditions. Total protein in urine was measured by a tur-
bidimetric method with 12.5% trichloroacetic acid at 420
nm [7,15] and the data were expressed as mg/24 h.
Histological studies
Thin slices of kidney tissue with cortex and medulla were
fixed by immersion in buffered formalin (pH 7.4), dehy-
drated and embedded in paraffin. Sections (4 µm) were
stained with hematoxylin and eosin (H&E) [15]. A quan-
titative histological damage was determined by using a
Leica Qwin Image Analyzer (Cambridge, UK). The histo-
logical profile of twenty proximal tubules randomly
selected per rat (5 rats per group) was recorded (n = 100
tubuli/group at each time point). The number of tubules
with histopathological alterations like swelling, cytoplas-
mic vacuolization, desquamation or necrosis was regis-
tered and the data were expressed as percentage of
damaged tubules. The percentage of damaged tubules of
K2Cr2O7 and control groups was compared.
Immunohistochemical localization of 3-NT, protein 
carbonyls, Cu, Zn-SOD, Mn-SOD, and CAT
For immunohistochemistry, 4 µm sections were deparaff-
ined with xylol and rehydrated with ethanol. Endogenous
peroxidase was quenched/inhibited with 4.5% H2O2 in
methanol by incubation for 1.5 h at room temperature.
The sections used for DNP immunohistochemistry were
incubated with 0.2% DNPH in 2 N HCl for 60 min at
room temperature in absence of light and then were
extensively washed with phosphate buffer saline. Nonspe-
cific adsorption was minimized by leaving the sections in
3% bovine serum albumin in phosphate buffer saline for
30 min. Sections were incubated overnight with a 1:700
dilution of anti-3-NT antibodies [15], or a 1:500 dilution
of anti-DNP antibodies, or a 1:250 dilution of anti Cu,
Zn-SOD antibodies, or a 1:500 dilution of anti Mn-SOD
antibodies, or a 1:500 dilution of anti CAT antibodies.
The sections were incubated with a 1:500 dilution of a
peroxidase conjugated anti-rabbit immunoglobulin anti-
bodies (for 3-NT, Cu, Zn-SOD, Mn-SOD, and CAT) or
with a 1:500 dilution of a peroxidase conjugated anti-goat
Ig (for DNP) for 1 h, and finally incubated with H2O2-
diaminobenzidine for 1 min. Sections were counter-
stained with hematoxylin and observed under light
microscopy. All the sections were incubated under the
same conditions with the same concentration of antibod-
ies, and in the same running, so the immunostaining was
comparable among the different experimental groups.
The stained area was quantified using a SigmaScan Pro
(version 4.01.003) (Jandel Scientific, San Rafael, CA). The
data are expressed as percent respect to day 0.
Urinary excretion of NO2
-/NO3
-
Nitric oxide (NO) is a labile substance with a short half-
life and it decomposes rapidly to NO2
- and NO3
- in bio-
logical solutions [36], and these stable breakdown prod-
ucts have been measured as an index of NO production
[37]. NO2
- and NO3
- were measured in the 24-hour urine
samples at all time points. Urine samples were firstBMC Nephrology 2005, 6:4 http://www.biomedcentral.com/1471-2369/6/4
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incubated with E. coli nitrate reductase to convert the NO3
-
to NO2
-, as described previously [38,39]. To prepare this
enzyme, E. coli was grown for 18 hours under anaerobic
conditions in nitrate rich medium, washed, resuspended
in phosphate buffer and frozen at -70°C until use. The
samples were incubated with the enzyme in phosphate
ammonium formate buffer (pH 7.3) for one hour at
37°C. After incubation, total NO2
- in the samples (repre-
senting both NO2
- and reduced NO3
-) was measured using
the Griess reagent. Known concentrations of NaNO2 and
NaNO3 were used as standards in each assay. Data were
expressed as nmol/min.
Activity of antioxidant enzymes
Kidney was homogenized in a Polytron (Model PT 2000,
Brinkmann, Westbury, NY, USA) for 10 seconds in cold
50 mM potassium phosphate, 0.1% Triton X-100, pH =
7.0. The homogenate was centrifuged at 19,000 × g and
4°C for 30 min and the supernatant was separated to
measure total protein and the activities of CAT, GPx, GR,
and total SOD.
Total SOD activity in renal cortex homogenates was
assayed spectrophotometrically at 560 nm by a previously
reported method using NBT as the indicator reagent [34].
The amount of protein that inhibited NBT reduction to
50% of maximum was defined as one unit of SOD activ-
ity. Results were expressed as U/mg protein. CAT activity
in renal cortex, was assayed by a method based on the dis-
appearance of 30 mM H2O2 at 240 nm [34] and the data
were expressed as k/mg protein. GPx activity in renal cor-
tex was measured at 340 nm using GR and NADPH in a
coupled reaction [34]. One unit of GPx was defined as the
amount of enzyme that oxidize 1 µmol of NADPH/min.
Data were expressed as U/mg protein. GR activity in renal
cortex was assayed using oxidized glutathione as substrate
and measuring the disappearance of NADPH at 340 nm
[34]. One unit of GR was defined as the amount of
enzyme that oxidize 1 µmol of NADPH/min. Data were
expressed as U/mg protein.
Western blot
Renal cortex (100 mg) was homogenized in 300 µl of
phosphate buffer 50 mM, pH 7.4 containing the follow-
ing cocktail of protease inhibitors: leupeptin 5 µg/ml,
pepstatin 7 µg/ml, aprotinin 5 µg/ml, and EDTA 1 mM.
The homogenates were centrifuged at 1,000 × g and 4°C
for 10 min. Thirty µg of protein were fractionated by
reducing 12.5% sodium dodecyl sulfate polyacrylamide
gel electrophoresis and electroblotted to a nitrocellulose
membrane (Hybond™ ECL™, Amersham, Buckingham-
shire, England). Immunodetection was performed using
specific primary antibodies against CAT (1:500 dilution),
Mn-SOD (1,5000 dilution), or Cu, Zn-SOD (1:5,000 dilu-
tion). Membranes were then probed with the appropriate
secondary antibody-peroxidase conjugate (1:5,000 dilu-
tion). The hybrids were visualized using ECL detection
system and quantified by densitometry (Sigma ScanPro,
version 4.0, San Rafael, CA, USA). Data were expressed as
% of the control.
Statistics
The data are expressed as the mean ± SEM and were ana-
lyzed by two-way analysis of variance followed by Bonfer-
roni t-test using the software Prism 2.01 (GraphPad, San
Diego, CA, USA). A P value less than 0.05 was considered
statistically significant.
Results and discussion
ROS have been involved in the pathophysiology of ARF
induced by K2Cr2O7 and some antioxidants are able to
ameliorate renal damage induced by this compound
[15,16,18,23,25]. In addition, it has been previously
Chromium concentration in (A) serum and (B) kidney in con- trol (❍ ) and K2Cr2O7 (● )-treated rats Figure 1
Chromium concentration in (A) serum and (B) kidney in con-
trol (❍ ) and K2Cr2O7 (● )-treated rats. Data are mean ± 
SEM. *P < 0.001 vs. control group. n = 3–6.
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shown that renal heme oxygenase-1 preinduction by
SnCl2 ameliorates ARF and prevents oxidative and nitrosa-
tive stress induced 24 h after K2Cr2O7 injection [15,34]. In
the present work we performed a time-course analysis of
the nephrotoxicity, oxidative and nitrosative stress, and
changes in antioxidant enzymes induced by K2Cr2O7.
Body weight of control and K2Cr2O7-treated rats was sim-
ilar at all time points (see additional file 1). Urinary vol-
ume was increased in K2Cr2O7-treated animals on days 3
(1.9-fold) and 4 (1.6-fold) and returned to control values
thereafter (see additional file 1). Polyuria observed in our
rats is consistent with previous data [2]. We measured the
chromium content in serum and kidney and it was found
that it increased on days 1–6 and 1–12, respectively (Fig.
1). In both cases the peak value was reached on day 1 and
then the chromium concentration decreased gradually,
but in kidney remained still significantly high on day 12
and in serum reached values not different from control
rats since day 6. Our data are consistent with previous
pharmacokinetic studies which have shown that chro-
mium is rapidly distributed [40] and that the half life of
chromium is longer in kidney than in blood serum [41].
(A) Creatinine clearance, (B) serum creatinine, and (C) blood  urea nitrogen control (❍ ) and K2Cr2O7 (● )-treated rats Figure 2
(A) Creatinine clearance, (B) serum creatinine, and (C) blood 
urea nitrogen control (❍ ) and K2Cr2O7 (● )-treated rats. 
Data are mean ± SEM. *P at least <0.05 vs. control group. n = 
4–6.
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Urinary excretion of (A) NAG and (B) total protein in con- trol (❍ ) and K2Cr2O7 (● )-treated rats Figure 3
Urinary excretion of (A) NAG and (B) total protein in con-
trol (❍ ) and K2Cr2O7 (● )-treated rats. Data are mean ± 
SEM. *P at least <0.05 vs. control group. n = 4–18.
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Representative images of histology (first row) and immunohistochemical detection of 3-NT (second row) and DNP (third row)  during the evolution of the kidney damage produced by K2Cr2O7 Figure 4
Representative images of histology (first row) and immunohistochemical detection of 3-NT (second row) and DNP (third row) 
during the evolution of the kidney damage produced by K2Cr2O7. The study was performed in control rats (day 0) and on days 
2 and 12 after a single injection of K2Cr2O7 (15 mg/Kg). (A) Normal kidney histology from control rat (H/E). (B) On day 2, 
there is extensive tubular damage manifested by swollen and necrotic epithelial cells (H/E). (C) total kidney regeneration has 
been produced on day 12 post K2Cr2O7 administration (H/E). (D) Normal kidney from control animals shows scarce 3-NT 
immunoreactivity. (E) On day 2, there is strong 3-NT immunostaining in the epithelium from the convoluted tubules. (F) Slight 
3-NT immunostaining is observed in the tubular epithelium on day 12. (G) Normal kidney from control rat shows scarce DNP 
immunostaining in the tubular epithelium. (H) In contrast, on day 2 there is clear DNP immunostaining in the cytoplasm and 
nucleus of the tubular epithelial cells and mesangium. (I) Slight DNP immunostaining is observed on day 12. 400 X.
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Markers of nephrotoxicity are shown in Figs. 2 and 3. Cre-
atinine clearance decreased on days 1–4 (Fig. 2A), and
serum creatinine and BUN increased on days 1–4 and 1–
6, respectively (Figs. 2B and 2C). Urinary excretion of
NAG and total protein increased on days 1–4 and 1–6,
respectively (Figs. 3A and 3B). The major damage was
observed on days 2–4 (Figs. 2 and 3). On day 8, all these
markers returned to control values indicating that
K2Cr2O7-induced ARF is reversible which is consistent
with previous observations [10]. These functional find-
ings are in a close agreement with the histological data.
Significant structural abnormalities were seen in the kid-
ney cortex since the first day after K2Cr2O7 administration.
Specifically, 50% of the epithelium from the proximal
convoluted tubules showed cellular swelling, necrosis and
partial or complete detachment from the basal mem-
brane. On day 2, when the peak of the tubular damage
was observed, 70% of the proximal convoluted tubules
was affected (Figs. 4B and 5). On days 3 and 4 proximal
convoluted tubules showing the above mentioned abnor-
malities decreased to 40 and 25%, respectively (Fig. 5).
On day 4, many tubules also showed numerous cellular
debris in their lumen and epithelium regeneration was
also seen but it was more evident on days 6 and 8 (data
not shown). On days 10 and 12 the kidney histology was
almost normal (Fig. 4C), only few tubules were revisted
by active regenerative epithelium (small cuboidal cells
with big nucleus and occasional mitotic figures). The high
levels of serum and kidney chromium correlated with the
structural and functional renal alterations on days 1–6.
Interestingly, the renal damage disappeared in spite of the
kidney still having high levels of chromium on days 8–12.
This may be explained by the fact that chromium (VI),
which is readily taken up into tissues, is reduced inside the
cell to the final stable product chromium (III) [19]. The
biological effects of chromium (VI) are generally attrib-
uted to cellular uptake, because chromium (VI), in con-
trast to chromium (III), is easily taken up by cells through
the sulfate anion transport system [42,43]. However, once
inside, chromium (VI) is reduced through reactive inter-
mediates such as chromium (V) and chromium (IV) to the
more stable chromium (III) by cellular reductants includ-
Table 1: Quantitative analysis of 3-NT, DNP, catalase, Cu, Zn-SOD, and Mn-SOD immunostaining.
D a y  0D a y  2D a y  1 2
3-Nitrotyrosine 100 ± 11 (4) 392 ± 33 (4)* 113 ± 13 (4)
Dinitrophenol 100 ± 11 (4) 172.03 ± 9* (4) 106.81 ± 9 (4)
Catalase 100 ± 6 (5) 82 ± 6.7 (4) 107 ± 4.9 (4)
Cu, Zn-SOD 100 ± 3 (4) 90 ± 8 (4) 91 ± 7 (4)
Mn-SOD 100 ± 5 (3) 94 ± 6 (3) 110 ± 5 (3)
Data are expressed as percentage vs. day 0. *P < 0.001 vs. day 0.
Number of rats studied are in parentheses.
Quantitative histological analysis in control (❍ ) and K2Cr2O7  (● )-treated rats Figure 5
Quantitative histological analysis in control (❍ ) and K2Cr2O7 
(● )-treated rats. Data are mean ± SEM. *P < 0.05 vs. control 
group. n = 20 tubules/rat and 5 rats/group.
Urinary excretion of NO2
-/NO3
- in control (❍ ) and K2Cr2O7  (● )-treated rats Figure 6
Urinary excretion of NO2
-/NO3
- in control (❍ ) and K2Cr2O7 
(● )-treated rats. Data are mean ± SEM. *P < 0.05 vs. Con-
trol group. n = 4–10.
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Representative immunohistochemical detection of CAT (first row), Cu, Zn-SOD (second row), and Mn-SOD (third row) dur- ing acute renal failure induced by K2Cr2O7 Figure 7
Representative immunohistochemical detection of CAT (first row), Cu, Zn-SOD (second row), and Mn-SOD (third row) dur-
ing acute renal failure induced by K2Cr2O7. The study was performed in control rats (day 0) and on days 2 and 12 after a single 
injection of K2Cr2O7 (15 mg/Kg). (A) Normal kidney from control rats shows intense CAT immunoreactivity in the proximal 
and distal convoluted tubules. (B) In contrast, kidney cortex on day 2 shows evident decrease of CAT immunostaining. (C) 
Strong CAT immunoreactivity in the tubular epithelium is observed on day 12. (D) Normal kidney from control animals also 
showed strong Cu, Zn-SOD immunostaining in the cortex convoluted tubules. This strong Cu, Zn-SOD immunoreactivity is 
also observed on day 2 (E) and on day 12 (F). A similar pattern of Mn-SOD immunostaining is observed in normal kidney from 
control rat (G), and after 2 (H) and 12 (I) days of K2Cr2O7 injection. A-C and G-I 100X, D-F 400X.
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ing glutathione, vitamins C and B2, and flavoenzymes
[42]. Thus, the formation of chromium (III) or other
intermediate oxidation states, in particular chromium
(V), is believed to play a role in the biological effect of
chromium (VI) compounds. In vitro studies have shown
that this reduction process causes the generation of active
oxygen species [44] which are involved in renal damage
[15,34]. Interestingly, it has been shown that a low dose
of K2Cr2O7 (10 mg/Kg) is unable to induce nephrotoxicity
suggesting a threshold of this compound to induce renal
damage [10]. In addition, it is know that chromium is
located in vacuoles inside the proximal tubular cells
which may delay the excretion of this metal [13]. In fact it
has been shown that chromium remains for a long time in
several tissues including kidney [13,40,41] which is con-
sistent with our data.
The histological abnormalities correlated with renal func-
tional alterations (days 1–6) and with the immunohisto-
chemical detection of 3-NT and protein carbonyls. DNPH
reacts with free carbonyls forming DNP-derived proteins
which can be detected using antibodies against DNP. Car-
bonyl derivatives are formed by ROS mediated oxidation
of side-chains of some amino acid residues and are impor-
tant detectable markers of oxidative damage to proteins
[45]. Kidneys from control non-treated animals did not
show or only had slight immunostaining to 3-NT or pro-
tein carbonyls (Figs. 4D and 4G), while kidneys from
K2Cr2O7-treated animals on day 2 showed strong 3-NT
immunostaining in necrotic and swollen tubular epithe-
lial cells, as well as some mesangial cells (Fig. 4E). This
increase was significative (P < 0.0001 vs. day 0) (Table 1).
In fact, it was observed from day 1 to day 8 (data not
shown). Protein carbonyls immunostaining was also clear
in the cytoplasm and nuclei from tubular epithelium and
mesangial glomerular cells at the same time points (Fig.
4H and data not shown) (P < 0.001 vs. day 0) (Table 1).
Then, on days 10 to 12, a striking decrease of 3-NT and
DNP immunostaining was seen, being similar to the
control non-treated rats (Figs. 4F and 4I). In previous
works, we also have found in K2Cr2O7-treated rats an
intense 3-NT immunostaining [15] and an increase in
protein carbonyl content [15,34]. Our data confirm that
ROS are involved in K2Cr2O7-induced nephrotoxicity
[16,17,19,26,44] which has additionally been supported
by the protective effect of several antioxidants in this
experimental model [21-25].
On the other hand, it was found that urinary excretion of
NO2
-/NO3
- decreased significantly in K2Cr2O7-treated rats
on days 2–6 (Fig. 6). Urinary excretion of NO2
-/NO3
- is
considered as an index of NO production [37] and there-
fore these data may suggest that NO production is
decreased in K2Cr2O7-treated rats. However, the strong
nitrosative stress observed in our rats by 3-NT immunos-
taining, may suggest that the decrease in urinary NO2
-/
NO3
-  excretion could be secondary to the NO
consumption by its reaction with superoxide anion to
generate peroxynitrite and other reactive nitrogen species
involved in protein tyrosine nitration [46]. This is sup-
ported by the association between the time course altera-
tions in 3-NT immunostaining (days 1–8) and the
decrease in urinary NO2
-/NO3
- excretion (days 2–6).
Further we investigated the time response of the renal
antioxidant enzymes in K2Cr2O7-treated rats. In control
rats, strong CAT immunostaining was seen in the epithe-
lial cells from proximal and distal convoluted tubules
(Fig. 7A). From day 2 to day 10 after K2Cr2O7 administra-
tion, CAT immunostaining showed striking decrease, par-
ticularly in the epithelium from tubules with evident
cellular damage (Fig. 7B and data not shown). Then, at
(A) Activity and (B) content of CAT in kidney from control  (❍ ) and K2Cr2O7 (● )-treated rats Figure 8
(A) Activity and (B) content of CAT in kidney from control 
(❍ ) and K2Cr2O7 (● )-treated rats. Data are mean ± SEM. *P 
at least <0.05 vs. control group. n = 4–6.
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day 12, when almost normal kidney histology was seen,
strong CAT immunostaining was observed in a similar
pattern than in the kidney from control animals (Fig. 7C).
CAT activity (Fig. 8A) and content (Fig. 8B) decreased on
days 2–10 and 3–10, respectively. In control animals the
epithelial cells from the proximal and convoluted tubules
showed strong immunoreactivity to Cu, Zn-SOD and Mn-
SOD (Figs. 7D and 7G). This pattern of immunostaining
did not show evident changes during the time course
study (days 1–12) (Figs. 7E, 7F, 7H, 7I, and data not
shown); even the damaged swollen epithelial tubular cells
exhibited strong immunostaining to both SOD enzymes.
These data are in agreement with kidney total SOD activ-
ity (Fig. 9) and with the protein content of Mn-SOD and
Cu, Zn-SOD measured by Western blot which remained
unchanged at all time points in K2Cr2O7-treated rats (data
not shown). Finally, the activity of GPx and GR decreased
on days 3–12 and on days 2–10, respectively (Fig. 10). It
is very clear from the above data that there was a differen-
tial response of the antioxidant enzymes to K2Cr2O7 injec-
tion. Interestingly, no enzyme (SOD, CAT, GPx, and GR)
was altered on day 1 when the kidney damage was very
severe. Surprisingly, SOD activity and content remained
essentially unchanged at all time points. This may be a
consequence of the fact that both SOD enzymes were
immunolocalized even in the damaged epithelial tubular
cells. In contrast, the other enzymes decreased to reach
their lowest values on day 6 returning then to basal values
by day 12 with the exception of GPx which remained low.
On days 2–6, there was some degree correlation between
CAT, GPx, and GR and the markers of nephrotoxicity.
However, from day 8 these enzymes remained low in spite
of renal function and structure returned to control. Fur-
thermore, the time course study suggests that the decrease
in GPx, GR, and CAT activities may be secondary to the
oxidative and nitrosative stress which are evident since
day 1. In fact, it has been demonstrated that peroxynitrite
impairs GPx activity [47] and superoxide anion inacti-
vates GPx [48] and CAT [49]. Interestingly, GR and CAT
remained low until day 10 and GPx remained low until
day 12 in absence of oxidative and nitrosative stress. The
reason why these enzymes remained low at the end of the
study is not clear, however we may speculate that factors
other than oxidative/nitrosative stress are involved in the
diminution in these enzymes and/or proximal tubules
have not reached yet the full capacity to synthesize these
enzymes. Therefore, additional studies are required to
explain why some antioxidant enzymes remained low on
days 10–12 in absence of oxidative/nitrosative stress.
Total superoxide dismutase activity in kidney from control  (❍ ) and K2Cr2O7 (● )-treated rats Figure 9
Total superoxide dismutase activity in kidney from control 
(❍ ) and K2Cr2O7 (● )-treated rats. Data are mean ± SEM. n = 
3–6.
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Activity of (A) glutathione peroxidase and (B) glutathione  reductase in kidney from control (❍ ) and K2Cr2O7 (● )- treated rats Figure 10
Activity of (A) glutathione peroxidase and (B) glutathione 
reductase in kidney from control (❍ ) and K2Cr2O7 (● )-
treated rats. Data are mean ± SEM. *P at least <0.05 vs. con-
trol group. n = 5–6.
0 2 4 6 8 10 12
0.00
0.05
0.10
0.15
*
*
* *
DAY
G
P
x
A
C
T
I
V
I
T
Y
U
/
m
g
p
r
o
t
e
i
n
* *
Treatment P<0.0001
Time P<0.0001
A
B
0 2 4 6 8 10 12
0.00
0.05
0.10
0.15
* *
* * * *
DAY
G
R
A
C
T
I
V
I
T
Y
U
/
m
g
p
r
o
t
e
i
n
Treatment P<0.0001
Time P<0.0001BMC Nephrology 2005, 6:4 http://www.biomedcentral.com/1471-2369/6/4
Page 11 of 12
(page number not for citation purposes)
Conclusion
The data show an association between oxidative/nitrosa-
tive stress and functional and structural renal damage
induced by K2Cr2O7 in rats at different time points, but
not between this damage and antioxidant enzymes.
List of abbreviations used
ARF Acute renal failure
BUN Blood urea nitrogen
CAT Catalase
Cu, Zn-SOD Copper and zinc superoxide dismutase
DNP Dinitrophenol
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GPx Glutathione peroxidase
GR Glutathione reductase
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K2Cr2O7 Potassium dichromate
Mn-SOD Manganese superoxide dismutase
NADPH Nicotinamide adenine dinucleotide phosphate
NAG N-acetyl-β -D-glucosaminidase
NBT Nitroblue tetrazolium
NO Nitric oxide
NO2
- Nitrate
NO3
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ROS Reactive oxygen species
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